Advancing Biomedical Engineering for Future Health
Biomedical engineering is a powerful driver of scientific translation, innovation, and economic growth - yet Europe still fails to fully realize its potential compared to the USA and Asia.
Recognizing this gap, EMBO and the Helmholtz Bioengineering Initiative convened at the EMBO Headquarters in Heidelberg and co-hosted leading voices from academia, industry, funding bodies, venture capital, and policy to discuss how biomedical engineering can be strengthened as a distinct, solution‑oriented field in Europe.
The workshop highlighted that successful bioengineering ecosystems require dedicated identity and training pathways, mission‑driven funding schemes, strong academia-industry interaction, and vibrant innovation hubs that bridge discovery and application. As a national and international platform, the Helmholtz Bioengineering Initiative is actively shaping this agenda - connecting disciplines, enabling translation, and fostering entrepreneurial pathways to engineer future health in Europe.
The detailed results of the workshop and its discussions will be published as a White Paper to inform funders, policy makers and academia.